CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy 10% owner bought 283,516 shares at $2.61 ($739,977)
- 4 Option exercise Chief Operating Officer acquired 83,334 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift 10% owner gave 210,000 shares (gift)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy Director bought 30,000 shares at an average $4.58 ($137,400)
- 4 Open-market buy Director bought 20,000 shares at $4.91 ($98,200)
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at $5.19 ($103,800)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy Director bought 30,000 shares at $5.90 ($177,000)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
Page 3 of 8 · 145 filings